Lilly to strengthen IO pipeline with $1.6B Armo acquisition

Eli Lilly and Co. (NYSE:LLY) is acquiring Armo BioSciences Inc. (NASDAQ:ARMO) for $50 per share in cash, or about $1.6 billion. The price is

Read the full 242 word article

User Sign In